Infant DevelopmentFILMNCT06278961
Families Filming Infants Learning Movement
An observational study of Infant Development and Cerebral Palsy, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.
Trial summary
The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical… Read more about this study
- Who is it for?
- Ages 10 to 20 weeksHealthy volunteers can take part
- Conditions the study is for
- Infant Development, Cerebral Palsy, Motor Disorders
- What is being tested?
- Observational
- How many people
- 350 participants
- Where
- 1 siteUnited States
- Study dates
- 28 Jan 2021to 30 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 20 weeks
- All sexes
- Healthy volunteers accepted
- Child
Study population: Infants aged 10-20 weeks adjusted age. Not of other target special populations.
Who may be able to join
- Infants born full-term with typical development, bithweight >2500g
- Infants with a history of brochopulmonary dysplasia, defined as having a preterm birth (<33 weeks gestational age) and requiring supplemental oxygen beyond 36 weeks gestational age
- Infants with neonatal encephalopathy, who required hypothermic cooling treatment
- Infants born <36 weeks gestational age
- Infants born in a multiple gestation pregnancy
- Infants with a diagnosis of Trisomy 21
- Infants born and diagnosed with SMA prenatally, via newborn screening assessment or prior to 10 weeks corrected age
- Infants are less than 10 weeks corrected age at time of enrollment
Who cannot join
- Children who are enrolled in DCFS custody
- Parent or infant guardian does not have a smartphone
Trial locations and contacts
1 site in 1 country.
United States1 site
Feinberg School of Physical Therapy and Human Movement Sciences
Chicago, Illinois, 60611
About this study
Official title: The Ontogeny of Fidgety Movements in Infants At High-Risk of Cerebral Palsy
The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical complexity. The study team plans to recruit 100 healthy, term-born infants and 250 infants at risk of developing CP for a total of 350 enrolled infants.
Read the detailed description
Research teams at Northwestern (Prentice), University of Sydney, Fondazione IRCCS Stella Maris, Cerebral Palsy Alliance (CPA) and Murdoch Children's Research Institute (MCRI) will be collecting data in the same manner using the Baby Moves app with the inclusion and exclusion criteria above. The data from the Baby Moves app will be temporarily stored in a common REDcap database at the Murdoch Children's Research Institute (MCRI) with all sites included. The MCRI has all necessary approvals in place to host the videos. Video files from Prentice and Lurie will be transferred to a common REDCap Database at Northwestern. Other sites (University of Sydney, MCRI, Stella Maris, CPA), will have their own REDCap databases where the data is stored and managed. The research teams at these sites will be responsible for recruiting and consenting subjects. All sites (except Prentice) will seek IRB approval from their respective sites.
Study design: Prospectively recruited cohort study.
Study procedures:
Eligible families will be identified using the Electronic Data Warehouse (Prentice), through Data Analytics and Reporting (DAR) Lurie, the electronic medical record platform EPIC, or through recruitment on social media websites and family advocacy websites. Families will be contacted via email and/or text message and will have the option to enroll through electronic consent (econsent) in order to minimize in-person contact. Participating families will be able to enroll online using REDCap. If the family has questions about enrollment or the consent form, they will be able to notify a member of the study team, using a survey form on REDCap. A member of the research team can contact the family by phone to provide information and answer questions about participating in the study. Participating families will then receive directions on the phone on how to use and download the Baby Moves app on their smartphones.
Participating families will download the Baby Moves app on their smartphones after enrollment. A member of the research team will register the infant into the study database, using a study ID, infant birth date, and infant due date. The participating families may watch a 3-minute demonstration video on use of the app and proper filming technique.
A member of the research team will also record the subject's pertinent medical information (neurological findings, gestational age at birth, birthweight and neonatal medical complications, severity of ROP, and treatment for ROP, if SMA: SMA type, SMN2 copy number if known, date of dx, and pharmacologic treatment, treatment for SMA and date of 1st treatment) into a REDcap database.
Parents will receive a reminder on their smartphone through both e-mail and push notification at required filming time points (10, 12, 14, 16, 18 and 20 weeks of corrected age). Families will be reminded to film the infant. Parents will receive the following family-friendly and standardized instructions for filming the baby:
All participants will be asked to upload video recordings using the Baby Moves app outside of their standard of care.
Infant videos will be uploaded into a HIPAA-compliant REDcap database and the research team will be notified when the family has taken the video using the app.
Two advanced-trained general movement assessors will independently review the video within 3-5 days of receiving it, using Prechtl methodology (see below). These assessors will be part of the study team from any of the participating sites but will be blinded to infant data and PHI.
General Movement Assessment: General movements are a developmentally regulated pattern of spontaneous motor activity, appearing in the embryo by 9 weeks post-conceptional age. By 50-55 weeks post-conceptional age (10-15 weeks post-term), the predominant general movements seen are termed Fidgety Movements - a pattern of continuous, small amplitude movements of the neck, trunk and limbs during wakefulness that disappear with agitation. These patterns are identifiable and are classified as normal if present (intermittent or continual), and abnormal if exaggerated (with respect to speed and amplitude), sporadic (interspersed with long pauses) or absent. Importantly, absence of these fidgety movements at 10-15 weeks post-term accurately predicts the development of cerebral palsy(4). Certified raters will use the 3-minute video filmed by families using the Baby Moves app to categorize infant general movements according to the Prechtl methodology(5) and to quantify movement patterns.
The family will be notified of the results within one week of uploading the final video at 20 weeks corrected age.
If the videos are deemed by raters to be normal, the family will receive notification by email.
If the infant's general movements are deemed to be high-risk, the participating family will receive a phone call and will be scheduled for a follow-up visit (either as an outpatient or in their home).
The families will not receive a formal diagnosis but will be triaged to a virtual visit from a physician or physical therapist. At this time they will receive 2 standardized developmental assessments: the Alberta Infant Motor Scale (AIMS) and a modified version of the Hammersmith Infant Neurological Examination (HINE). These videos will be completed using the videoconferencing software Zoom (hosted through. The study team will use the waiting room feature to minimize loss of confidentiality risk. The files from these encounters will be stored in FSM resfiles and/or on encrypted devices.
Infants with high-risk general movements will additionally be referred to local Early Intervention Services.
For the very few cases of enrolled participants who take videos from Prentice Women's Hospital or Lurie Children's Hospital and who are deemed high-risk. the investigators will share the risk level based on the study's screening with a clinician in charge of developmental care (such as Dr. Raye-Anne deRegnier, who also happens to be a co-investigator on this study). The investigators can communicate with the clinical care team so that the team can accurately and unambiguously share the participants study screening results with the family. In this special case, the investigators will send a follow up email to families thanking them for participating and letting the families know that the investigators have shared the result with the developmental team at their respective Hospital.
Video data from the Baby Moves app will be securely stored in the REDCap database.
Duration of the Study: Infants will be followed for 5 years. Data will be collected until the target of 450 subjects is achieved for all sites.
For follow-up the infants will be grouped into two categories:
- Children who are enrolled in a high-risk follow-up clinic
- Children who are not enrolled in a high-risk follow-up clinic
Infants in group 1 (enrolled in high-risk follow-up clinic) Infants from all sites who are already enrolled in a high-risk follow-up clinic, will be followed for five years, using site-specific standardized neurodevelopmental outcome measures, which are routinely done in their respective follow-up clinics. If enrolled in an SMA follow up clinic a similar follow up protocol will take place, using site specific SMA, motor function outcome measures, which are routinely done in their respective follow-up clinics. Data will be collected from standard visit data and entered into REDCap.
Infants in group 2: Will be asked to complete surveys at 1 and 2 years of corrected age called the Ages and Stages questionnaire. They will send this survey back electronically or by mail.
The difference between groups 1 and 2 is that group 1 will not be asked to complete the Ages and Stages questionnaires at 1 and 2 years of age.
All families from groups 1 and 2 will fill out a survey about the Baby Moves app that will be completed electronically. Each questionnaire will take approximately 5-15 minutes to complete. Infants from all sites may also receive follow-up phone calls that will be completed by the parents at 12 and 24 months. These phone surveys will require 1-3 minutes of the parents time.
Data including names, addresses, names, dates, telephone numbers, addresses, email, infant's medical history, video data, questionnaire results and neurodevelopmental tests will be collected prospectively.
Researchers from all sites will have access to the REDcap database. This REDCap database will be managed by Northwestern University. Data use agreements are being established among sites.
Additionally, individual expert raters in the general movement assessment from additional institutions, working as content experts will also have access to de-identified and coded data
While they will not have personal health identifiers, these raters will be able to see the face of the infants in the videos. The facial expressions and movements of these infants are required in rating the videos. The observation of faces are not considered to be identifiers due to the young age of the subjects and their quickly changing appearance.
ONE YEAR FOLLOW-UP Infants recruited will receive a one-year-old birthday card from the study team, and their families will complete a 12-month Ages and Stages Questionnaire at their child's 12 month corrected age as a global developmental screening with a member of the study team.
TWO-YEAR FOLLOW-UP, NEURODEVELOPMENTAL ASSESSMENTS Participating families will return for a two-year follow-up visit and will receive the following batteries of standardized assessments.
Table 1. Two-year neurodevelopmental assessment battery
Assessment name
Assessment requirements
Constructs assessed
Bayley Scales of Infant and Toddler Development, version 4 (Bayley-4)
Trained assessor, standardized test kit with manipulatives, stimulus book, manual
Cognitive, language, motor skills, norm-referenced
Infant Toddler Quality of Life Questionnaire (ITQOL)
Parent questionnaire
Quality of Life
Child Behavior Checklist (CBCL)
Parent questionnaire
Socioemotional
Gross motor functional measure (GMFM)-66*
Trained assessor, manual, standardized equipment
Motor ability in children diagnosed with cerebral palsy
*Only infants diagnosed with CP will be tested with the GMFM-66
The investigators will also record whether a child has received a diagnosis of CP. If they have not received a diagnosis but have high-risk based on two-year presentation, the investigators will refer patients for diagnostic follow-up and then record outcome of that diagnosis.
- Being tested
- Observational
- Keywords
- fidgety movements, general movement assessment, cerebral palsy
- Medical subject headings
- Cerebral Palsy, Motor Disorders, Nervous System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ObservationalOther
Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.
| Study group | Role | What they receive |
|---|---|---|
| Conrols - health term infants | Infants, less than 10 weeks of age at enrolment who were born full-term with typical development, birthweight >2500g Receives: Other: Observational | |
| Bronchopulmonary dysplaspia | A history of bronchopulmonary dysplasia, defined as having a preterm birth (<33 weeks' gestational age) and requiring supplemental oxygen beyond 36 weeks' gestational age Receives: Other: Observational | |
| Neonatal encephalopathy | term born infants who required hypothermic cooling treatment or had a diagnosis of hypoxic ischemic encephalopathy Receives: Other: Observational | |
| Congenital anomalies | Congenital anomalies of any kind eg cardiac, musculoskeletal, gastrointestinal Receives: Other: Observational | |
| Preterm birth | Preterm birth <36 weeks gestational age Receives: Other: Observational | |
| Multiple gestation | One of a multiple gestation pregnancy Receives: Other: Observational |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fidgety Movements in healthy, term born infants
Identify the timeframe in which fidgety movements are consistently present in healthy, term born infants
Measured: 4 months
Fidgety Movements in children with a range of medical complexities
Identify the time frame in which fidgety movements are consistently present in children with a range of medical complexities
Measured: 4 months
Fidgety Movements and two-year Neurodevelopmental outcomes in health, term born infants
Identify the timeframe in which fidgety movements are most accurate in prediction of two-year neurodevelopmental outcomes in healthy, term born infants
Measured: 2 years
Fidgety Movements and two-year Neurodevelopmental outcomes in children with a range of medical complexities
Identify the timeframe in which fidgety movements are most accurate in prediction of two-year neurodevelopmental outcomes in children with a range of medical complexities
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Feb 2024
- Study start28 Jan 2021
- Primary completion30 Sep 2026 (estimated)
- Study completion30 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Infant DevelopmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 350 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Sponsor type
- University, hospital or other
- Collaborators
- Northwestern University, IRCCS Fondazione Stella Maris, University of Sydney, University of Melbourne
- Responsible party
- Principal investigator, Colleen Peyton, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06278961
- Sponsor's protocol ID
- IRB 2021-4329
- Acronym
- FILM
- Status last verified
- Sep 2026
- First submitted
- 19 Feb 2024
- Last updated
- 3 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Costagli G, Rocchitelli L, Chorna O, Del Secco S, Corsi G, Peyton C, Spittle AJ, Kwong AK, Guzzetta A. Feasibility of the Baby Moves app for remote General Movements Assessment: a prospective observational cohort study in an Italian infant population. BMJ Paediatr Open. 2026 Jul 6;10(1):e004361. doi: 10.1136/bmjpo-2025-004361.
PubMed 42413968
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Ontogeny of Fidgety Movements in Infants At High-Risk of Cerebral Palsy
- ClinicalTrials.gov ID
- NCT06278961
- Acronym / sponsor ID
- FILM / IRB 2021-4329
- Keywords
- fidgety movements, general movement assessment, cerebral palsy
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 350 participants (estimated)
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of ChicagoUniversity, hospital or other
- Collaborators
- Northwestern University, IRCCS Fondazione Stella Maris, University of Sydney, University of Melbourne
- Study start
- 28 Jan 2021 (actual)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 30 Sep 2026 (estimated)
- First posted
- 26 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical complexity. The study team plans to recruit 100 healthy, term-born infants and 250 infants at risk of developing CP for a total of 350 enrolled infants.
Detailed description
Research teams at Northwestern (Prentice), University of Sydney, Fondazione IRCCS Stella Maris, Cerebral Palsy Alliance (CPA) and Murdoch Children's Research Institute (MCRI) will be collecting data in the same manner using the Baby Moves app with the inclusion and exclusion criteria above. The data from the Baby Moves app will be temporarily stored in a common REDcap database at the Murdoch Children's Research Institute (MCRI) with all sites included. The MCRI has all necessary approvals in place to host the videos. Video files from Prentice and Lurie will be transferred to a common REDCap Database at Northwestern. Other sites (University of Sydney, MCRI, Stella Maris, CPA), will have their own REDCap databases where the data is stored and managed. The research teams at these sites will be responsible for recruiting and consenting subjects. All sites (except Prentice) will seek IRB approval from their respective sites.
Study design: Prospectively recruited cohort study.
Study procedures:
Eligible families will be identified using the Electronic Data Warehouse (Prentice), through Data Analytics and Reporting (DAR) Lurie, the electronic medical record platform EPIC, or through recruitment on social media websites and family advocacy websites. Families will be contacted via email and/or text message and will have the option to enroll through electronic consent (econsent) in order to minimize in-person contact. Participating families will be able to enroll online using REDCap. If the family has questions about enrollment or the consent form, they will be able to notify a member of the study team, using a survey form on REDCap. A member of the research team can contact the family by phone to provide information and answer questions about participating in the study. Participating families will then receive directions on the phone on how to use and download the Baby Moves app on their smartphones.
Participating families will download the Baby Moves app on their smartphones after enrollment. A member of the research team will register the infant into the study database, using a study ID, infant birth date, and infant due date. The participating families may watch a 3-minute demonstration video on use of the app and proper filming technique.
A member of the research team will also record the subject's pertinent medical information (neurological findings, gestational age at birth, birthweight and neonatal medical complications, severity of ROP, and treatment for ROP, if SMA: SMA type, SMN2 copy number if known, date of dx, and pharmacologic treatment, treatment for SMA and date of 1st treatment) into a REDcap database.
Parents will receive a reminder on their smartphone through both e-mail and push notification at required filming time points (10, 12, 14, 16, 18 and 20 weeks of corrected age). Families will be reminded to film the infant. Parents will receive the following family-friendly and standardized instructions for filming the baby:
All participants will be asked to upload video recordings using the Baby Moves app outside of their standard of care.
Infant videos will be uploaded into a HIPAA-compliant REDcap database and the research team will be notified when the family has taken the video using the app.
Two advanced-trained general movement assessors will independently review the video within 3-5 days of receiving it, using Prechtl methodology (see below). These assessors will be part of the study team from any of the participating sites but will be blinded to infant data and PHI.
General Movement Assessment: General movements are a developmentally regulated pattern of spontaneous motor activity, appearing in the embryo by 9 weeks post-conceptional age. By 50-55 weeks post-conceptional age (10-15 weeks post-term), the predominant general movements seen are termed Fidgety Movements - a pattern of continuous, small amplitude movements of the neck, trunk and limbs during wakefulness that disappear with agitation. These patterns are identifiable and are classified as normal if present (intermittent or continual), and abnormal if exaggerated (with respect to speed and amplitude), sporadic (interspersed with long pauses) or absent. Importantly, absence of these fidgety movements at 10-15 weeks post-term accurately predicts the development of cerebral palsy(4). Certified raters will use the 3-minute video filmed by families using the Baby Moves app to categorize infant general movements according to the Prechtl methodology(5) and to quantify movement patterns.
The family will be notified of the results within one week of uploading the final video at 20 weeks corrected age.
If the videos are deemed by raters to be normal, the family will receive notification by email.
If the infant's general movements are deemed to be high-risk, the participating family will receive a phone call and will be scheduled for a follow-up visit (either as an outpatient or in their home).
The families will not receive a formal diagnosis but will be triaged to a virtual visit from a physician or physical therapist. At this time they will receive 2 standardized developmental assessments: the Alberta Infant Motor Scale (AIMS) and a modified version of the Hammersmith Infant Neurological Examination (HINE). These videos will be completed using the videoconferencing software Zoom (hosted through. The study team will use the waiting room feature to minimize loss of confidentiality risk. The files from these encounters will be stored in FSM resfiles and/or on encrypted devices.
Infants with high-risk general movements will additionally be referred to local Early Intervention Services.
For the very few cases of enrolled participants who take videos from Prentice Women's Hospital or Lurie Children's Hospital and who are deemed high-risk. the investigators will share the risk level based on the study's screening with a clinician in charge of developmental care (such as Dr. Raye-Anne deRegnier, who also happens to be a co-investigator on this study). The investigators can communicate with the clinical care team so that the team can accurately and unambiguously share the participants study screening results with the family. In this special case, the investigators will send a follow up email to families thanking them for participating and letting the families know that the investigators have shared the result with the developmental team at their respective Hospital.
Video data from the Baby Moves app will be securely stored in the REDCap database.
Duration of the Study: Infants will be followed for 5 years. Data will be collected until the target of 450 subjects is achieved for all sites.
For follow-up the infants will be grouped into two categories:
- Children who are enrolled in a high-risk follow-up clinic
- Children who are not enrolled in a high-risk follow-up clinic
Infants in group 1 (enrolled in high-risk follow-up clinic) Infants from all sites who are already enrolled in a high-risk follow-up clinic, will be followed for five years, using site-specific standardized neurodevelopmental outcome measures, which are routinely done in their respective follow-up clinics. If enrolled in an SMA follow up clinic a similar follow up protocol will take place, using site specific SMA, motor function outcome measures, which are routinely done in their respective follow-up clinics. Data will be collected from standard visit data and entered into REDCap.
Infants in group 2: Will be asked to complete surveys at 1 and 2 years of corrected age called the Ages and Stages questionnaire. They will send this survey back electronically or by mail.
The difference between groups 1 and 2 is that group 1 will not be asked to complete the Ages and Stages questionnaires at 1 and 2 years of age.
All families from groups 1 and 2 will fill out a survey about the Baby Moves app that will be completed electronically. Each questionnaire will take approximately 5-15 minutes to complete. Infants from all sites may also receive follow-up phone calls that will be completed by the parents at 12 and 24 months. These phone surveys will require 1-3 minutes of the parents time.
Data including names, addresses, names, dates, telephone numbers, addresses, email, infant's medical history, video data, questionnaire results and neurodevelopmental tests will be collected prospectively.
Researchers from all sites will have access to the REDcap database. This REDCap database will be managed by Northwestern University. Data use agreements are being established among sites.
Additionally, individual expert raters in the general movement assessment from additional institutions, working as content experts will also have access to de-identified and coded data
While they will not have personal health identifiers, these raters will be able to see the face of the infants in the videos. The facial expressions and movements of these infants are required in rating the videos. The observation of faces are not considered to be identifiers due to the young age of the subjects and their quickly changing appearance.
ONE YEAR FOLLOW-UP Infants recruited will receive a one-year-old birthday card from the study team, and their families will complete a 12-month Ages and Stages Questionnaire at their child's 12 month corrected age as a global developmental screening with a member of the study team.
TWO-YEAR FOLLOW-UP, NEURODEVELOPMENTAL ASSESSMENTS Participating families will return for a two-year follow-up visit and will receive the following batteries of standardized assessments.
Table 1. Two-year neurodevelopmental assessment battery
Assessment name
Assessment requirements
Constructs assessed
Bayley Scales of Infant and Toddler Development, version 4 (Bayley-4)
Trained assessor, standardized test kit with manipulatives, stimulus book, manual
Cognitive, language, motor skills, norm-referenced
Infant Toddler Quality of Life Questionnaire (ITQOL)
Parent questionnaire
Quality of Life
Child Behavior Checklist (CBCL)
Parent questionnaire
Socioemotional
Gross motor functional measure (GMFM)-66*
Trained assessor, manual, standardized equipment
Motor ability in children diagnosed with cerebral palsy
*Only infants diagnosed with CP will be tested with the GMFM-66
The investigators will also record whether a child has received a diagnosis of CP. If they have not received a diagnosis but have high-risk based on two-year presentation, the investigators will refer patients for diagnostic follow-up and then record outcome of that diagnosis.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Conrols - health term infants | – | Other: ObservationalInfants, less than 10 weeks of age at enrolment who were born full-term with typical development, birthweight >2500g |
| Bronchopulmonary dysplaspia | – | Other: ObservationalA history of bronchopulmonary dysplasia, defined as having a preterm birth (<33 weeks' gestational age) and requiring supplemental oxygen beyond 36 weeks' gestational age |
| Neonatal encephalopathy | – | Other: Observationalterm born infants who required hypothermic cooling treatment or had a diagnosis of hypoxic ischemic encephalopathy |
| Congenital anomalies | – | Other: ObservationalCongenital anomalies of any kind eg cardiac, musculoskeletal, gastrointestinal |
| Preterm birth | – | Other: ObservationalPreterm birth <36 weeks gestational age |
| Multiple gestation | – | Other: ObservationalOne of a multiple gestation pregnancy |
Who may qualify
- Ages
- 10 to 20 weeks
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Infants aged 10-20 weeks adjusted age. Not of other target special populations.
Key inclusion criteria (8 listed)
- Infants born full-term with typical development, bithweight >2500g
- Infants with a history of brochopulmonary dysplasia, defined as having a preterm birth (<33 weeks gestational age) and requiring supplemental oxygen beyond 36 weeks gestational age
- Infants with neonatal encephalopathy, who required hypothermic cooling treatment
- Infants born <36 weeks gestational age
- Infants born in a multiple gestation pregnancy
Key exclusion criteria (2 listed)
- Children who are enrolled in DCFS custody
- Parent or infant guardian does not have a smartphone
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ObservationalObservation of movement patterns through video recordings and neurodevelopmental battery of assessments. | Other | Bronchopulmonary dysplaspia, Congenital anomalies, Conrols - health term infants, Multiple gestation, Neonatal encephalopathy, Preterm birth |
Primary outcome
Fidgety Movements in healthy, term born infants
Time frame: 4 months
Identify the timeframe in which fidgety movements are consistently present in healthy, term born infants
Fidgety Movements in children with a range of medical complexities
Time frame: 4 months
Identify the time frame in which fidgety movements are consistently present in children with a range of medical complexities
Fidgety Movements and two-year Neurodevelopmental outcomes in health, term born infants
Time frame: 2 years
Identify the timeframe in which fidgety movements are most accurate in prediction of two-year neurodevelopmental outcomes in healthy, term born infants
Fidgety Movements and two-year Neurodevelopmental outcomes in children with a range of medical complexities
Time frame: 2 years
Identify the timeframe in which fidgety movements are most accurate in prediction of two-year neurodevelopmental outcomes in children with a range of medical complexities
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
- Derived from this study: PubMed 42413968Costagli G, Rocchitelli L, Chorna O, Del Secco S, Corsi G, Peyton C, Spittle AJ, Kwong AK, Guzzetta A. Feasibility of the Baby Moves app for remote General Movements Assessment: a prospective observational cohort study in an Italian infant population. BMJ Paediatr Open. 2026 Jul 6;10(1):e004361. doi: 10.1136/bmjpo-2025-004361.
- Individual participant dataSharing planned: No
Related trials for Infant Development
Not yet recruitingObservational study
Multimodal Mechanical, Tissue, Architectural, and Histological Evaluation of the Bone and Sutures of the Parietal Bone in an Infant With Craniosynostosis.
Craniostenosis
RecruitingObservational study
Natural History of Noncirrhotic Portal Hypertension
Cystic Fibrosis, Immunologic Deficiency Syndrome
Recruiting
Nutritional Maturity in Preterm Newborns (Premature Infant Oral Motor Intervention, PIOMI)
Preterm, Preterm Infant Development
Recruiting
Effect of Developmental Care on Very Low Birth Weight Infants
Intervention
RecruitingObservational study
Role of Genetic Factors in the Development of Lung Disease
Cystic Fibrosis, Pulmonary Fibrosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Infant Development and Cerebral Palsy, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fidgety Movements in healthy, term born infants (time frame: 4 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06278961, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.